Verition Fund Management
BBNX

Verition Fund Management’s Beta Bionics BBNX Stock Holding History

Verition Fund Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,427
Closed -$255K – 2623
2026
Q1 		$255K Sell
25,427
-57,435
-69% -$850K ﹤0.01% 1854
2025
Q4 		$2.52M Buy
82,862
+35,563
+75% +$950K 0.01% 1401
2025
Q3 		$940K Buy
47,299
+1,823
+4% +$32K ﹤0.01% 2580
2025
Q2 		$662K Buy
45,476
+18,259
+67% +$258K ﹤0.01% 2764
2025
Q1 		$333K Buy
+27,217
New +$507K ﹤0.01% 2815

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Verition Fund Management's BBNX Position: Q2 2026 in Review

Verition Fund Management sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 25,427 shares — an estimated $255K sold.

Verition Fund Management first reported a position in BBNX in Q1 2025 and held it in 5 quarters. The position peaked at $2.52M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Verition Fund Management reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 25,427 Beta Bionics shares in Q2 2026, an estimated $255K.
  • Verition Fund Management first reported a position in Beta Bionics in Q1 2025 and held it in 5 quarters.
  • Verition Fund Management's Beta Bionics position peaked at $2.52M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.